Followers | 14 |
Posts | 1446 |
Boards Moderated | 0 |
Alias Born | 02/28/2011 |
Thursday, March 23, 2017 10:53:32 AM
As always, you provide good insight. I apologize for not responding sooner as I'm sure it kept you up at night....haha, jk.
My day job has been very busy lately and haven't had a chance to response or look at any specifics in regards to BCLI company position and possible deals, etc.
Without researching beyond your post, what I do know about China is they're one of the leading countries in stem cell research (which you probably already know). I think Israel is in the top 10 so that's good and US is slowly coming around. On a side note, I think South Korea is the top stem cell research country.. I'll have to do research on that. With that said, a potential partnership will benefit BCLI however, with the recent hire of Dr. Kern, I'd like to see BCLI operate without partnerships who may want to chip away about potential profits. I think Dr. Kern's background will benefit BCLI on a global scale as he is familiar with global distribution solutions which they can provide patient care. Like you said, foreign policies can be an obstacle but I believe BCLI will work with countries who favor stem cell research/treatment first and others later. For instance, the potential to treat Canadian citizens since their regs aren't as strict as FDA. I think by BCLI focusing on those countries who like stem cell treatment, this will allow them to gain a strategic advantage over competition especially since their trying to treat ALS.
As for raising additional cash, I agree with you in there needs to be another way to do it. I think management has done a good job so far with raising capital without hurting shareholders. the only issue I had with them was the RS, I was down over 40% but held through so they could up list to NASDAQ (as I mentioned before). Recently, I was up over 60% (just under $7,000) total so, I sold all my shares to lock in those gains and at the moment, I'm buying again. I believe in this company and what they're doing. I removed my emotions to make the money that I did and now, I'm taking a smaller stake.
Overall, I like the companies potential. I've mentioned this before and as long as they don't get loans or other companies involved to help fund Phase 3 or other areas, i think that's ideal. they can do what they want with raising capital through stock offerings because in the short term, the stock may take a hit but long term investors will see the potential and hold.
Recent BCLI News
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 09/17/2024 07:32:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/16/2024 08:36:41 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/09/2024 04:15:04 AM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 08/28/2024 09:01:02 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 08/16/2024 11:00:19 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 12:01:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2024 11:15:21 AM
- Form PRER14A - Preliminary Proxy Soliciting materials • Edgar (US Regulatory) • 08/06/2024 08:59:18 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 08/05/2024 09:11:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/30/2024 08:05:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/24/2024 08:05:18 PM
- BCLI Update - Progress Supports Our 10x Plus Value Range Potential • PR Newswire (Canada) • 07/24/2024 12:30:00 PM
- BCLI Update - Progress Supports Our 10x Plus Value Range Potential • PR Newswire (US) • 07/24/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/19/2024 08:05:57 PM
- Initiation - Potential 10x Return on Successful Phase 3b. Promising Post Hoc and Biomarker Analysis Underpins Our NurOwn® Clinical Effectiveness Expectation • PR Newswire (US) • 06/14/2024 04:01:00 PM
- Initiation - Potential 10x Return on Successful Phase 3b. Promising Post Hoc and Biomarker Analysis Underpins Our NurOwn® Clinical Effectiveness Expectation • PR Newswire (Canada) • 06/14/2024 04:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 10:05:20 AM
FEATURED Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM